Fig. 5From: Targeting SNHG3/miR-186-5p reverses the increased m6A level caused by platinum treatment through regulating METTL3 in esophageal cancera Dual luciferase activity for SNHG3 and miR-186-5p. b miR-186-5p expression in SNHG3-WT overexpression KY-SE150. c miR-186-5p expression in SNHG3-Mut overexpression KY-SE150. d RNA pull down for SNHG3 and miR-186-5pBack to article page